These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 3969067)

  • 21. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
    Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites.
    Severson JA; Randall PK
    J Pharmacol Exp Ther; 1985 May; 233(2):361-8. PubMed ID: 3158731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
    Panagopoulos NT; Matsokis NA; Valcana T
    J Neurosci Res; 1993 Aug; 35(5):499-506. PubMed ID: 8377223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analysis of the interaction of [3H]spiroperidol with serotonin and dopamine receptors.
    McGonigle P
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S73-7. PubMed ID: 2459520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kainate lesion dissociates striatal dopamine receptor radioligand binding sites.
    Leff S; Adams L; Hyttel J; Creese I
    Eur J Pharmacol; 1981 Mar; 70(1):71-5. PubMed ID: 7215442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors.
    Levant B; DeSouza EB
    Synapse; 1993 May; 14(1):90-5. PubMed ID: 8099762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assay of dopamine receptors with [alpha-3H]flupenthixol.
    Huff RM; Molinoff PB
    J Pharmacol Exp Ther; 1985 Jan; 232(1):57-61. PubMed ID: 3965700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland.
    Lin C; McGonigle P; Molinoff PB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):950-6. PubMed ID: 2958621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine receptors labelled by PHNO.
    Seeman P; Ulpian C; Larsen RD; Anderson PS
    Synapse; 1993 Aug; 14(4):254-62. PubMed ID: 7902615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist interactions with dopamine receptors: focus on radioligand-binding studies.
    Creese I; Sibley DR; Leff SE
    Fed Proc; 1984 Oct; 43(13):2779-84. PubMed ID: 6383871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
    Roberts DJ; Lin H; Strange PG
    Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H]domperidone binding to the kidney inner medullary collecting duct dopamine-2K (DA2K) receptor.
    Huo T; Healy DP
    J Pharmacol Exp Ther; 1991 Aug; 258(2):424-8. PubMed ID: 1830902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
    Chio CL; Lajiness ME; Huff RM
    Mol Pharmacol; 1994 Jan; 45(1):51-60. PubMed ID: 8302280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]Pramipexole: a selective radioligand for the high affinity dopamine D2 receptor in bovine striatal membranes.
    Ohnmacht U; Tränkle C; Mohr K; Gmeiner P
    Pharmazie; 1999 Apr; 54(4):294-7. PubMed ID: 10234741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
    Cumming P; Wong DF; Gillings N; Hilton J; Scheffel U; Gjedde A
    J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
    Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
    Seeman P; Ko F; Willeit M; McCormick P; Ginovart N
    Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.